分子搭桥术与缺血性心脏病
摘要
治疗性血管新生 (分子搭桥术 )与缺血、缺氧、生长因子、一氧化氮及一些物理刺激等有密切关系 ,动物实验及临床研究均表明 ,分子搭桥术具有良好的应用前景 ,对于严重的冠心病患者是一种新的治疗方法。
出处
《心脏杂志》
CAS
2001年第5期409-410,共2页
Chinese Heart Journal
参考文献13
-
1[1]Schape W. Molecular mechanisms of coronary collateral vessel growth[J]. Circ Res, 1996, 79(5):911-919.
-
2[2]Banai S, Jaklitsch MT, Shou M, et al. Angiogenic induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs[J]. Circulation, 1994, 89(5):2183-2189.
-
3[3]Takeshita S, Weir L, Chen D, et al. Therapeutics angiogensis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model[J]. J Clin Invest, 1994,93(2):662-670.
-
4[4]Takeshita S. Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency[J]. Am J Pathol, 1995,147(6):1649-1660.
-
5[5]Isner JM, Pieczek A, Walsh K, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF in patient with ischemic limb[J]. Lancet, 1996,348(9024): 370-374.
-
6[6]Henry TD , Rocha-singh K, Inser JM, et al. Results of intracoronary recombinant human vascular endothelial growh factor administration trial[J]. Circulation, 1998,97(2): 65A.
-
7[7]Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogensis: initial clinical results with direct myocardial injection of phVEGF as sole therapy for myocardial ischemic[J]. Circulation, 1998,98(25):2800-2804.
-
8[8]Laham RJ, Sellke FW, Edelmen ER, et al. Local perivascular bFGF treatment in patients with ischemic heart disease[J]. Am Coll Cardiol, 1998,31(suppl A):394A.
-
9[9]Murohara T ,Asahara T, Silver M, et al. Nitric oxide synthese modulates angiogenesis in response to tissue ischemic[J]. J Clin Invest, 1998,101(11):2567-2578.
-
10[10]Fabre J ,Rivard A, Magner M, et al. Tissue inhibition of angiotensin converting enzyme activity stimulates angiogenesis[J]. Circulation, 1999,99(23):3043-3049.
-
1陈倩亮.冠心病的分子搭桥疗法[J].健康博览,2000(6):21-21.
-
2刘海淑.心血管病与基因治疗[J].实用心脑肺血管病杂志,2005,13(3):187-188.
-
3钱宏法,黄淑君,王平,金雪琴,赵晓英.下蹲位终止阵发性室上性心动过速（附3例报告）[J].苏州大学学报（医学版）,1994,21(6):530-530.
-
4陈仕林,张宝仁,梅举.缺血性心脏病“分子搭桥”研究现状与展望[J].中华心血管病杂志,2001,29(8):507-509. 被引量：2
-
5薛树仁.分子搭桥术生成新血管治疗冠心病的展望[J].中国分子心脏病学杂志,2002,2(2):87-89.
-
6周建光,刘长云,黄亚莉.冠心病“分子搭桥”方法临床研究进展[J].心血管康复医学杂志,2003,12(1):87-90.
-
7袁红,陈君柱.内皮祖细胞与糖尿病血管病变的血管新生[J].国外医学（内分泌学分册）,2005,25(2):114-116.
-
8顾俊彦,黄盛东,梅举.缺血性心脏病中的治疗性血管新生[J].江苏大学学报（医学版）,2002,12(1):94-96. 被引量：1
-
9任崇雷,杨明,高长青.血管内皮生长因子联合骨髓间充质干细胞治疗缺血性心肌病的应用前景[J].现代保健（医学创新研究）,2006(10):13-16.
-
10关勤,刘浩,刘志勇.前列腺素E1促进大鼠急性心肌梗死模型血管内皮生长因子表达及量效关系研究[J].现代医学,2006,34(5):309-313. 被引量：1
